Researchers from Biomedicine Discovery Institute (BDI) at Monash University in Australia have found that an anti-parasitic drug called Ivermectin could kill the novel coronavirus, SARS-CoV-2, within 48 hours in a laboratory setting.
Monash University, in alliance with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), led the study.
Ivermectin holds the US Food and Drug Administration (FDA) approval as an anti-parasitic medicine. In-vitro, the drug demonstrated activity against different viruses including HIV, dengue, influenza and Zika.
According to findings from the latest study, a single dose of the drug could stop SARS-CoV-2 growing in cell culture within two days.